3063 POSTER Capecitabine (C), in combination with irinotecan (I) and oxaliplatin (O) (XELOXIRI) as first-line treatment of metastatic colorectal cancer (MCRC): results of a pilot study by the Gruppo Oncologico Nord-Ovest (G.O.N.O.)

Autor:	Silvana Chiara, Alfredo Falcone, M. T. Barletta, Elisabetta Pfanner, Giacomo Giulio Baldi, Gianluca Masi, Andrea Antonuzzo, Fotios Loupakis, S. Bursi, Iacopo Petrini
Rok vydání:	2007
Předmět:	Oncology Cancer Research medicine.medical_specialty Colorectal cancer business.industry medicine.disease Oxaliplatin Capecitabine First line treatment Irinotecan Internal medicine medicine business medicine.drug
Zdroj:	European Journal of Cancer Supplements. 5:255
ISSN:	1359-6349
DOI:	10.1016/s1359-6349(07)70991-6
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f748ec5e56465ea60a51e3bc85b3919d https://doi.org/10.1016/s1359-6349(07)70991-6 Zobrazit plný text záznamu Full Text from ScienceDirect